Companies: 10,795·Total market cap: $144.5T
Entero Therapeutics, Inc.

Entero Therapeutics, Inc.

ENTONASDAQHealthcare
$2.85
$-0.15(-5.00%)
Market Cap$13582331
P/E Ratio
52W High$5.84
52W Low$0.969
Overview

Entero Therapeutics, Inc.(ENTO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ENTO · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.04M$0.00M$0.00M$0.00M$0.00M
Cost of Revenue$0.00M$0.00M$0.03M$0.11M$0.54M
Gross Profit$0.00M$0.00M($0.03M)($0.11M)($0.54M)
Gross Margin %(computed)0.00%
Operating Expenses
R&D Expenses$0.93M$0.00M$5.03M$0.69M$38.32M
G&A Expenses$5.50M$0.01M$10.74M$11.99M$18.38M
Total Operating Expenses$6.43M$0.02M$15.77M$12.68M$56.70M
Operating Income($7.08M)($0.02M)($15.77M)($12.68M)($59.06M)
Operating Margin %(computed)
Interest Income$0.00M$0.00M$0.00M$0.01M$0.00M
Interest Expense($0.49M)$0.00M$0.02M$0.02M$0.01M
Income Before Tax($6.55M)($0.02M)($15.79M)($14.63M)($58.54M)
Income Tax Expense$0.00M($0.00M)$0.00M$0.00M$0.00M
Net Income($6.55M)($18.06M)($15.79M)($14.63M)($58.54M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-4.16$-3.88$-46.96$-407.37$-27544.98
Wtd Avg Shares1.62M4.65M0.34M0.04M0.00M
EBITDA($7.08M)$0.03M($15.74M)($14.58M)($57.99M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Entero Therapeutics, Inc.

关于Entero Therapeutics, Inc.(ENTO)损益表

Entero Therapeutics, Inc.(ENTO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ENTO实现营收$0.00B,毛利润$0.00B(毛利率0.00%),净利润($0.01B)(净利率-18078.34%)。

常见问题

ENTO · 4 问

Entero Therapeutics, Inc.(ENTO)2025财年营收为$0.00B,同比up—%。

ENTO revenueENTO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09